Technical Analysis for PTGX - Protagonist Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 13.74 3.31% 0.44
PTGX closed up 3.31 percent on Friday, March 22, 2019, on 1.91 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical PTGX trend table...

Date Alert Name Type % Chg
Mar 22 Pocket Pivot Bullish Swing Setup 0.00%
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 22 Up 3 Days in a Row Strength 0.00%
Mar 22 Up 4 Days in a Row Strength 0.00%
Mar 22 Up 5 Days in a Row Strength 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 Pocket Pivot Bullish Swing Setup 3.31%
Mar 21 Calm After Storm Range Contraction 3.31%

Older signals for PTGX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Medicine Biopharmaceutical Medical Specialties Immunology Autoimmune Diseases Inflammatory Bowel Disease Ulcerative Colitis Abdominal Pain Crohn's Disease Colitis Hepcidin
Is PTGX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.0
52 Week Low 5.49
Average Volume 158,869
200-Day Moving Average 8.2081
50-Day Moving Average 8.6286
20-Day Moving Average 10.054
10-Day Moving Average 11.543
Average True Range 0.6141
ADX 50.37
+DI 52.6241
-DI 5.3843
Chandelier Exit (Long, 3 ATRs ) 12.1577
Chandelier Exit (Short, 3 ATRs ) 8.9223
Upper Bollinger Band 13.9086
Lower Bollinger Band 6.1994
Percent B (%b) 0.98
BandWidth 76.677939
MACD Line 1.4147
MACD Signal Line 0.9696
MACD Histogram 0.4451
Fundamentals Value
Market Cap 232.23 Million
Num Shares 16.9 Million
EPS -3.23
Price-to-Earnings (P/E) Ratio -4.25
Price-to-Sales 0.00
Price-to-Book 4.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.09
Resistance 3 (R3) 15.03 14.51 14.87
Resistance 2 (R2) 14.51 14.17 14.55 14.79
Resistance 1 (R1) 14.13 13.96 14.32 14.19 14.71
Pivot Point 13.61 13.61 13.71 13.65 13.61
Support 1 (S1) 13.23 13.27 13.42 13.29 12.77
Support 2 (S2) 12.71 13.06 12.75 12.69
Support 3 (S3) 12.33 12.71 12.62
Support 4 (S4) 12.39